Mio Yamamoto‐Sugitani

Frequent <i>PVT1</i> Rearrangement and Novel Chimeric Genes <i>PVT1-NBEA</i> and <i>PVT1-WWOX</i> Occur in Multiple Myeloma with 8q24 Abnormality

Hisao Nagoshi, Tomohiko Taki, Ichiro Hanamura et al. · Cancer Research · 2012 · 101 citations

Medicine, Genetics, Oncology +9

Galectin-3 (Gal-3) induced by leukemia microenvironment promotes drug resistance and bone marrow lodgment in chronic myelogenous leukemia

Mio Yamamoto‐Sugitani, Junya Kuroda, Eishi Ashihara et al. · Proceedings of the National Academy of Sciences · 2011 · 100 citations · Full text

Medicine, Cell Biology, Oncology +15

Phosphoinositide Protein Kinase PDPK1 Is a Crucial Cell Signaling Mediator in Multiple Myeloma

Yoshiaki Chinen, Junya Kuroda, Yuji Shimura et al. · Cancer Research · 2014 · 34 citations

Medicine, Cell Biology, Oncology +17

Clinical manifestation of angioimmunoblastic T-cell lymphoma with exuberant plasmacytosis

Hisao Nagoshi, Junya Kuroda, Tsutomu Kobayashi et al. · International Journal of Hematology · 2013 · 33 citations

Medicine, Hematology, Oncology +11

FTY720 induces apoptosis of chronic myelogenous leukemia cells via dual activation of BIM and BID and overcomes various types of resistance to tyrosine kinase inhibitors

Miki Kiyota, Junya Kuroda, Mio Yamamoto‐Sugitani et al. · APOPTOSIS · 2013 · 32 citations

Medicine, Oncology, Pharmacology +16